惠陶集團(08238.HK)至4月止六個月總收益增2.9倍
惠陶集團(08238.HK)公布,至4月底止六個月未經審核營運業績,總收益為2,173.1萬元,按年升289.37%。
毛利為1,138.8萬元,按年升1,137.83%。
公司指,去年11月公司控制權變更後,集團進一步擴展其核心業務(包括廣告業務以及展覽及展出業務)。
公司又指,由於香港近期的社會動盪局勢及目前的冠狀病毒爆發,消費者對廣告的消費情緒已經減弱,預期多項活動及展覽延期舉行。預測集團未來數月的估計收益及毛利可能轉差,但仍預計錄得同期估計業績上升。此外,隨著預期經濟復甦,集團表現預計在下半年恢復。集團將繼續盡最大努力實施其業務發展計劃並改善集團的財務表現。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.